Subscribe To
Why equitrans midstream stock is skyrocketing today
The current version of a bill to raise the U.S. debt limit includes provisions to approve permits for t...
May 30, 2023, 11:18 am
News nuggets | 30 may: huobi hk launches; us approves eurex btc futures
Huobi HK Starts Services Huobi HK, the Hong Kong-based subsidiary of the global crypto exchange, is now offering spot cryptocurrency trading services ...
May 30, 2023, 10:27 am
Genprex wins approval to advance phase 2 expansion of acclaim-1 trial of reqorsa combined with tagrisso in advanced non-small cell lung cancer
Genprex Inc. revealed that it has completed the Phase 1 portion of the Acclaim-1 Phase 1/2 clinical trial evaluating REQORSA Immunogene therapy combi...
May 30, 2023, 9:32 am
Aussie unchanged ahead of lowe, cpi
RBA testifies before a Senate Committee Australia releases CPI US debt ceiling deal likely to be approve...
May 30, 2023, 8:54 am
Can you get preapproved for a small business loan before the business starts?
“The thing is like this…” Immediately, Chu Shaoyan told Toyotomi Maaya what happened. 。 As it got to the end, Qing’er’s voice became quiet...
May 30, 2023, 7:44 am
Krystal clear: krystal biotech clears resistance in good volume
Last week, shares of the Pittsburgh-based genetic medicines developer surged more than 25% after the FDA appro...
May 30, 2023, 7:36 am
Coherent expected restructuring charges of up to $200 million; stock extends rally
Coherent Corp. COHR, +14.02% disclosed Tuesday that it expects to record $150 million to $200 million in charges related to a restructuring plan...
May 30, 2023, 6:42 am
Debt ceiling negotiators reach a deal: 5 essential reads about the tentative accord, brinkmanship and the danger of default
By Bryan Keogh, The Conversation and Matt Williams, The Conversation President Joe Biden and House Speaker Kevin McCarthy on May 27, 2023, agreed in p...
May 29, 2023, 4:03 pm
Schlumberger: a good company in an uninspiring business
Schlumberger announced revenue of $7.736 billion in Q1'23, or a 29.8% increase YoY, down 1.8% over 4Q22. Schlumberger's board of directors...
May 29, 2023, 7:48 am
Ultragenyx: a promising bet on rare genetic disorder therapies
Ultragenyx's pipeline boasts a diverse array of gene therapy candidates, including UX111, DTX401, DTX301, and UX701, offering transformative potential...
May 29, 2023, 7:15 am
Pound sterling price news and forecast: gbp/usd has recovered amid a sell-off in the usd index
House of Representatives Kevin McCarthy-led Republicans have approved a raise in the $31.4 trillion US ...
May 29, 2023, 2:29 am
Eur/usd price analysis: volatile action looks likely as us debt-ceiling raise proposal approved
The EUR/USD pair is showing a back-and-forth action above the round-level support of 1.0700 in the Asian session. The major currency pair is expected ...
May 29, 2023, 1:29 am
Graniteshares announces change in etf lineup
NEW YORK, May 26, 2023 (GLOBE NEWSWIRE) — GraniteShares announced today that it will close and liquidate the following ETF: Ticker Fund Name Commenc...
May 26, 2023, 8:30 pm
U.s. fda approves lexicon pharma's heart failure drug
The U.S. Food and Drug Administration (FDA) has approved Lexicon Pharmaceuticals Inc's drug as a broad ...
May 26, 2023, 4:14 pm
Pfizer's (pfe) covid-19 oral treatment gets fda nod in adults
Per the FDA, Pfizer's (PFE) Paxlovid is the first oral antiviral pill approved in the United States to ...
May 26, 2023, 12:20 pm
2 biotech stocks that could help set you up for life
Axsome has two approved treatments as well as candidates in late-stage development Vertex has the domin...
May 26, 2023, 9:37 am
Holcim completes its share buyback program
This is equivalent to 6.0% of its share capital, for a total amount of CHF 2 billion at an average purchase price of CHF 54.3 per share. Cancellation ...
May 26, 2023, 5:44 am
Roche to present new data in blood cancers and solid tumours from its broad portfolio at asco 2023
Basel, 26 May 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) will be presenting new data on six approved and...
May 26, 2023, 1:00 am
Intra-cellular therapies: depression data boosts investment prospects (rating upgrade)
Intra-Cellular's drug Caplyta (lumateperone) is advancing through trials for major depressive disorder (MDD), expanding its...
May 25, 2023, 7:51 pm
Microsoft leaps into the ai regulation debate, calling for a new us agency and executive order
Microsoft joined a sprawling global debate on the regulation of artificial intelligence Thursday, echoing calls for a new federal agency to control th...
May 25, 2023, 1:18 pm